Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"Pyrazolo[4"”.

  1. The Preparation and Properties of some Pyrazolo/1, 5-c/Pyramidines and Pyrazolo/1, 5-c/Quinazolines

    Four types of pyrazolopyrimidines can theoretically exist. Pyrazolo |3,4-d| pyrimidines and pyrazolo|4, 3-d|pyrimidines do not contain a bridgehead nitrogen atom, and their syntheses and properties are reported elsewhere. Pyrazolo||,5-alpyrimidines and pyrazolo|1,5-c|pyrimidines contain a nitrogen …

    aston Download PDF for The Preparation and Properties of some Pyrazolo/1, 5-c/Pyramidines and Pyrazolo/1, 5-c/Quinazolines (opens in a new tab)

  2. Design and Synthesis of Pyrimidine Based Fused Heterocyclics in the Potential Treatment of Cancer and Opportunistic Infection

    … and tricyclic thieno[2,3-d]pyrimidines and pyrazolo[4,3-d]pyrimidines and discusses novel synthetic strategies for substituted thieno[2,3-d]pyrimidines and pyrazolo[4,3-d]pyrimidines. Pneumocystis pneumonia (PCP) is a form of pneumonia that is caused by the yeast-like fungus Pneumocystis …

    duquesne Repository record for Design and Synthesis of Pyrimidine Based Fused Heterocyclics in the Potential Treatment of Cancer and Opportunistic Infection (opens in a new tab)

  3. DESIGN AND SYNTHESIS OF FUSED PYRIMIDINES AS SINGLE AGENTS WITH COMBINATION CHEMOTHERAPY POTENTIAL, AS TUBULIN POLYMERIZATION AND ONE-CARBON METABOLISM INHIBITORS FOR CANCER

    … focuses on the development of substituted-pyrazolo[4,3-d]pyrimidines and thieno[3,2-d]pyrimidines to combat the above-mentioned drawbacks of clinically used antifolates. The work described herein discusses our efforts to obtain agents with the potential of inhibiting multiple intracellular …

    duquesne Repository record for DESIGN AND SYNTHESIS OF FUSED PYRIMIDINES AS SINGLE AGENTS WITH COMBINATION CHEMOTHERAPY POTENTIAL, AS TUBULIN POLYMERIZATION AND ONE-CARBON METABOLISM INHIBITORS FOR CANCER (opens in a new tab)